Siemens Healthineers AG (SHL.DE) stock analysis

In our weekly check, Siemens Healthineers AG is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 4, red flags: 0.

About Siemens Healthineers AG

Siemens Healthineers AG is a Healthcare company (Medical - Devices) based in Germany, listed on XETRA as SHL.DE.

What our checks show for SHL.DE

Warning signs

• Revenue grew only 2.2% a year over the last 3 years.
• The net margin is only 9.6%: little room if costs rise.
• The stock has fallen as much as 50% from a peak. Would you have held through that?
• The stock is still below its previous peak.

Strengths

• Operating profit covers interest 8.4 times over.
• Operating cash flow is 1.37x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 14.5% a year over the next years.
• A large company: market value $52.44 billion.
• Pay in shares is only 0% of free cash flow.

Next earnings report: 2026-11-05

Similar companies

EW · BSX · GEHC · DXCM · PHIA.AS · ZBH

Questions

What grade does Siemens Healthineers AG (SHL.DE) have?

In our weekly check, Siemens Healthineers AG is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 4, red flags: 0. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SHL.DE stock?

This week's biggest flags for Siemens Healthineers AG: Weak revenue growth, Thin margins, Deep past fall. In total 4 of 25 checks show a warning or a red flag.

What does Siemens Healthineers AG do?

Siemens Healthineers AG is a Healthcare company (Medical - Devices) based in Germany, listed on XETRA as SHL.DE.

When does Siemens Healthineers AG report earnings next?

The next earnings report is expected on 2026-11-05. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis